| Screening of pH-responsive long-circulating polysaccharide–drug conjugate nanocarriers for antitumor applications X Zhang, D Li, J Huang, K Ou, B Yan, F Shi, J Zhang, J Zhang, J Pang, ... Journal of materials chemistry B 7 (2), 251-264, 2019 | 43 | 2019 |
| Mutated SPOP E3 ligase promotes 17βHSD4 protein degradation to drive androgenesis and prostate cancer progression L Shi, Y Yan, Y He, B Yan, Y Pan, JJ Orme, J Zhang, W Xu, J Pang, ... Cancer research 81 (13), 3593-3606, 2021 | 20 | 2021 |
| MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression Z Huang, B Tang, Y Yang, Z Yang, L Shi, Y Bai, B Yan, RJ Karnes, ... Cancer research 81 (17), 4471-4484, 2021 | 11 | 2021 |
| SETDB1 modulates degradation of phosphorylated RB and anticancer efficacy of CDK4/6 inhibitors Z Huang, X Li, B Tang, H Li, J Zhang, R Sun, J Ma, Y Pan, B Yan, Y Zhou, ... Cancer research 83 (6), 875-889, 2023 | 9 | 2023 |
| Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer Y Wang, H Lei, B Yan, S Zhang, B Xu, M Lin, X Shuai, J Huang, J Pang Acta Biomaterialia 168, 593-605, 2023 | 7 | 2023 |
| Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis R Sun, B Yan, H Li, D Ding, L Wang, J Pang, D Ye, H Huang Cancer research 83 (19), 3192-3204, 2023 | 4 | 2023 |
| Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P‐Glycoprotein and Ferroptosis Y Guan, H Lei, C Xing, B Yan, B Lin, X Yang, H Huang, Y Kang, J Pang Advanced Healthcare Materials 13 (3), 2301345, 2024 | 1 | 2024 |
| ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment H Chen, C Xing, H Lei, B Yan, H Zhang, T Tong, Y Guan, Y Kang, J Pang Journal of Controlled Release 368, 637-649, 2024 | | 2024 |
| Delivery of mRNA Vaccine with 1, 2‐Diesters‐Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy Y Xu, Y Hu, H Xia, S Zhang, H Lei, B Yan, ZX Xiao, J Chen, J Pang, ... Advanced Healthcare Materials 13 (5), 2302691, 2024 | | 2024 |
| Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer H Liang, C Yang, R Zeng, Y Song, J Wang, W Xiong, B Yan, X Jin Advanced Science 10 (36), 2302368, 2023 | | 2023 |
| Immunohistochemical Staining of CD8 Protein in Tissue Sections from Patients with Tumors S Zhang, J Wang, J Fang, B Yan, H Xiong, F Shi, G Liao, X Lu, J Pang | | |
